EXERCISE PROGRAM FOR THE PREVENTION OF OSTEOPOROTIC FRACTURE
With
Belinda Beck,
Professor of Exercise Science,
Griffith University &
Owner and Director, The Bone Clinic &
Member of Medical and Scientific Advisory Committee
Healthy Bones Australia (formerly Osteoporosis Australia)
RESEARCHER PROFILE
Filmed in Southport, Queensland, Australia | May 2025
Dr Beck is an international leader in the effects of mechanical loading on bone health. Dr Beck graduated from The University of Queensland (BHMS[Ed]) and the University of Oregon (MSc and PhD) and completed a postdoctoral research fellowship in the Stanford University School of Medicine (California, USA.) She is a Professor of Exercise Science at Griffith University Gold Coast campus, where she has led the Bone Densitometry Research Laboratory since 2004.
Dr Beck has been awarded $7.6M in research grant funding to work on both animal and human models, from basic to clinical research. She has extensive experience leading clinical trials and the development of methodologies in musculoskeletal measurement. Her particular focuses have been exercise interventions across the lifespan for bone health, and bone stress injuries in athlete and military populations. In recent years she developed the first effective exercise program for the prevention of osteoporotic fracture.
The impact and significance of her work are reflected in 108 peer-reviewed journal articles (80% Q1 journals, 83.3% in top 25% journals by CiteScore), 7 chapters and 16 consumer publications in her field. Over 35% of her publications are in the top 10% most viewed publications worldwide (SciVal).
She has supervised 11 PhD, 5 Masters and 13 Honours students to completion and is currently supervising 2 PhD students, 1 Masters and 1 Honours student, along with three research associates (fellows and assistants). She has delivered 40 invited presentations worldwide (e.g., London, Italy, France, Germany, and the USA) and 57 nationally. She is a Board member of the International Osteoporosis Foundation Capture the Fracture programme, Sports Medicine Australia, the Australian and New Zealand Bone and Mineral Society and a Fellow of the American Society of Bone and Mineral Research, the American College of Sports Medicine, Sports Medicine Australia and Exercise Sports Science Australia.
Dr Beck’s research impact stems from the results of successful and innovative clinical trials and methodological studies that have changed practice in the fields of osteoporosis and military medicine and research practice. The implementation of her research outcomes in the real world seek to make genuine and significant differences to the quality and productivity of people.
Source: Adapted from supplied copy
-
Good and bad extracellular vesicles in health and disease
Associate Professor Joy Wolfram has joint appointments in the School of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland, and through her work at the AIBN, she aims to develop a new paradigm of therapeutics (using nanotechnology and cell products) to treat life-threatening diseases that are major causes of death globally, including cardiovascular disease, kidney disease, and breast cancer.
-
Anaemia guidelines updated after 50 years
Professor Sant-Rayn Pasricha is the Acting Deputy Director at the Walter Eliza Hall Institute of Medical Research in Melbourne, Australia. He is also a clinical haematologist at the Royal Melbourne Hospital and the Peter MacCallum Cancer Centre. From a young age, Prof Pasricha dreamed of becoming a doctor and found joy in learning about the human body and how to care for patients. After completing medical school, he developed a passion for working in low and middle-income countries, which led him to spend time working in East Timor, India, and Central Australia with First Nations communities.
-
DNA repair on the Fanconi anaemia pathway
Associate Professor Wayne Crismani is an internationally recognised expert in DNA repair, with a particular focus on Fanconi anaemia (FA)—a cancer-predisposition and bone marrow failure syndrome marked by extreme sensitivity to DNA damage. Based at St Vincent’s Institute in Melbourne, he leads a research program dedicated to understanding the genetic, cellular, and reproductive consequences of FA. He is currently supported by a Victorian Cancer Agency Mid-Career Fellowship and funding from the National Health and Medical Research Council.
